Nanotechnology may provide hope for patients with glucose transporter type 1 deficiency syndrome

Epileptic Disord. 2022 Jun 1;24(3):630-632. doi: 10.1684/epd.2022.1427.
No abstract available

MeSH terms

  • Carbohydrate Metabolism, Inborn Errors* / diagnosis
  • Carbohydrate Metabolism, Inborn Errors* / genetics
  • Humans
  • Monosaccharide Transport Proteins / deficiency
  • Monosaccharide Transport Proteins / genetics
  • Nanotechnology

Substances

  • Monosaccharide Transport Proteins

Supplementary concepts

  • Glut1 Deficiency Syndrome